Streetbeat News

Regulatory

ICCM

IceCure Medical Ltd. (NASDAQ:ICCM) has received a Notice of Allowance from the USPTO for a continuation patent on its 'Cryogenic Pump' technology, enhancing its global IP leadership in cryoablation technologies. This patent broadens the applications of IceCure's platform, with over 50 patents issued worldwide.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 12:32 pm

AZTR

Azitra has initiated a Phase 1b clinical trial for ATR-12, targeting Netherton Syndrome. The trial will involve 12 adults over 14 days, with interim safety data expected in early 2025 and full results in the second half of 2025.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 12:31 pm

WATT

Energous Corporation (NASDAQ:WATT) has received full FCC certification for its 2W PowerBridge transmitter system, marking it as the first certified transmitter at this power level. This system enhances wireless power networks by providing up to 8W EIRP, improving supply chain visibility and enabling continuous wireless power and real-time data for connected devices.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 12:31 pm

ARQT

Arcutis Biotherapeutics reported positive long-term results from its INTEGUMENT-OLE study, demonstrating the efficacy and safety of Roflumilast Cream 0.05% for treating mild to moderate atopic dermatitis in children. The company plans to submit a supplemental New Drug Application (sNDA) to the FDA in Q1 2025.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 12:07 pm

GMGI

Golden Matrix Group is expanding its presence in the iGaming market by applying for a license in New Jersey, obtaining a license in Bulgaria, and targeting Brazil's $20 billion market through its subsidiary, Meridianbet.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 12:06 pm

BIOR

Biora Therapeutics has been granted an extension by Nasdaq to regain compliance with its listing requirements. This extension provides the company with additional time to meet the necessary criteria to remain listed on the exchange.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 12:01 pm

BTCUSD

Arthur Hayes, co-founder of BitMEX, suggests that the Federal Reserve's monetary policy may be influenced by the upcoming U.S. presidential election, potentially leading to interest rate cuts to stimulate the stock market. This could result in increased liquidity and a bullish market sentiment.

Portfolio Pulse from Murtuza Merchant

August 28, 2024 | 11:39 am

COSM

VRAX

Virax Biolabs Group Limited (NASDAQ:VRAX) has signed a distribution agreement for Mpox virus detection kits in Europe and the Middle East. The kits are approved for sale in Europe and authorized by the UK's regulatory agency. Cosmos Health Inc. (NASDAQ:COSM) retains distribution rights in Greece, Cyprus, and non-exclusive rights across Europe. VRAX stock was down 4.70% in premarket trading.

Portfolio Pulse from Vandana Singh

August 28, 2024 | 11:16 am

VRAX

Virax Biolabs has announced that its RT PCR Mpox virus detection kits are CE-marked for sale in Europe and authorized by the UK's MHRA, indicating regulatory approval for these markets.

Portfolio Pulse from Benzinga Newsdesk

August 28, 2024 | 11:15 am

META

Nearly half of OpenAI's AGI safety researchers have resigned, citing a shift in focus from safety to commercial product development. This includes notable figures like Jan Hendrik Kirchner and cofounder John Schulman. The resignations highlight a broader debate on AI safety and regulation, with OpenAI facing criticism for opposing California's AI regulation bill. In response, OpenAI has appointed Irina Kofman, a former Meta executive, to focus on safety and preparedness.

Portfolio Pulse from Benzinga Neuro

August 28, 2024 | 10:47 am